Evommune
(NYSE) EVMN
Evommune Financials at a Glance
Market Cap
$710.64M
Revenue (TTM)
$10.00M
Net Income (TTM)
-$75.99M
EPS (TTM)
-$2.39
P/E Ratio
-8.26
Dividend
$0.00
Beta (Volatility)
1.81 (High)
Dividend
$0.00
Beta (Volatility)
1.81 (High)
Price
$19.78
Volume
0
Open
$20.05
Price
$19.78
Volume
0
Open
$20.05
Previous Close
$19.78
Daily Range
$19.53 - $20.06
52-Week Range
$13.89 - $33.20
Dividend
$0.00
Beta (Volatility)
1.81 (High)
Price
$19.78
Volume
0
Open
$20.05
Previous Close
$19.78
Daily Range
$19.53 - $20.06
52-Week Range
$13.89 - $33.20
EVMN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evommune
Industry
Biotechnology
Sector
Health CareEmployees
48
CEO
Luis C. Peña
Website
www.evommune.comHeadquarters
Palo Alto, CA 94304, US
EVMN Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-9%
Net Income Margin
-8%
Return on Equity
-104%
Return on Capital
-29%
Return on Assets
-24%
Earnings Yield
-12.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$710.64M
Shares Outstanding
36.02M
Volume
0
Avg. Volume
343.21K
Financials (TTM)
Gross Profit
$13.00M
Operating Income
-$81.07M
EBITDA
-$79.68M
Operating Cash Flow
-$76.44M
Capital Expenditure
-$235.00K
Free Cash Flow
-$76.68M
Cash & ST Invst.
$149.20M
Total Debt
$2.06M
Evommune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$349.00K
-113.3%
Gross Margin
0.00%
N/A
Market Cap
$710.64M
N/A
Market Cap/Employee
$15.79M
N/A
Employees
45
N/A
Net Income
-$21.67M
-48.9%
EBITDA
-$23.61M
-66.5%
Quarterly Fundamentals
Net Cash
$202.35M
+240.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.30M
-96.2%
Short Term Debt
$1.82M
+143.9%
Return on Assets
-23.57%
N/A
Return on Invested Capital
-28.86%
N/A
Free Cash Flow
-$27.59M
-15.4%
Operating Cash Flow
-$27.50M
-15.1%